Immediate Impact
55 standout
Citing Papers
Pancreatic cancer: Advances and challenges
2023 Standout
Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO Guideline
2021 Standout
Works of T. Giannakakis being referenced
A randomized study of epirubicin monotherapy every four or every two weeks in advanced breast cancer. A Hellenic Cooperative Oncology Group study
1997
A phase II study of paclitaxel in advanced breast cancer resistant to anthracyclines
1996
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| T. Giannakakis | 363 | 88 | 59 | 119 | 24 | 453 | |
| Mario Rabinovich | 335 | 109 | 65 | 113 | 17 | 463 | |
| T. Habeshaw | 290 | 71 | 80 | 78 | 27 | 504 | |
| M Namer | 266 | 113 | 31 | 84 | 36 | 432 | |
| S. Rigatos | 380 | 191 | 53 | 94 | 31 | 482 | |
| V. Barbounis | 224 | 112 | 23 | 80 | 31 | 465 | |
| E. Pasquini | 244 | 180 | 30 | 86 | 35 | 457 | |
| Mariangela Ciccarese | 314 | 136 | 30 | 153 | 31 | 469 | |
| Vincenzo Rosario Iaffaioli | 310 | 76 | 28 | 60 | 25 | 511 | |
| Smitha Menon | 293 | 125 | 45 | 71 | 17 | 457 | |
| Hideo Morino | 209 | 172 | 99 | 108 | 24 | 507 |
All Works
Loading papers...